547 related articles for article (PubMed ID: 29725335)
1. C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration.
Molins B; Romero-Vázquez S; Fuentes-Prior P; Adan A; Dick AD
Front Immunol; 2018; 9():808. PubMed ID: 29725335
[TBL] [Abstract][Full Text] [Related]
2. Activation of C-reactive protein proinflammatory phenotype in the blood retinal barrier
Romero-Vázquez S; Adán A; Figueras-Roca M; Llorenç V; Slevin M; Vilahur G; Badimon L; Dick AD; Molins B
Aging (Albany NY); 2020 Jul; 12(14):13905-13923. PubMed ID: 32673285
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration.
Bhutto IA; Baba T; Merges C; Juriasinghani V; McLeod DS; Lutty GA
Br J Ophthalmol; 2011 Sep; 95(9):1323-30. PubMed ID: 21633121
[TBL] [Abstract][Full Text] [Related]
4. Novel Programmed Cell Death as Therapeutic Targets in Age-Related Macular Degeneration?
Yang M; So KF; Lam WC; Lo ACY
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019767
[TBL] [Abstract][Full Text] [Related]
5. Interlink between Inflammation and Oxidative Stress in Age-Related Macular Degeneration: Role of Complement Factor H.
Romero-Vazquez S; Llorens V; Soler-Boronat A; Figueras-Roca M; Adan A; Molins B
Biomedicines; 2021 Jun; 9(7):. PubMed ID: 34209418
[TBL] [Abstract][Full Text] [Related]
6. Parainflammation associated with advanced glycation endproduct stimulation of RPE in vitro: implications for age-related degenerative diseases of the eye.
Lin T; Walker GB; Kurji K; Fang E; Law G; Prasad SS; Kojic L; Cao S; White V; Cui JZ; Matsubara JA
Cytokine; 2013 Jun; 62(3):369-81. PubMed ID: 23601964
[TBL] [Abstract][Full Text] [Related]
7. Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration.
Tuo J; Bojanowski CM; Zhou M; Shen D; Ross RJ; Rosenberg KI; Cameron DJ; Yin C; Kowalak JA; Zhuang Z; Zhang K; Chan CC
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3827-36. PubMed ID: 17652758
[TBL] [Abstract][Full Text] [Related]
8. Autophagy, exosomes and drusen formation in age-related macular degeneration.
Wang AL; Lukas TJ; Yuan M; Du N; Tso MO; Neufeld AH
Autophagy; 2009 May; 5(4):563-4. PubMed ID: 19270489
[TBL] [Abstract][Full Text] [Related]
9. Decreased membrane complement regulators in the retinal pigmented epithelium contributes to age-related macular degeneration.
Ebrahimi KB; Fijalkowski N; Cano M; Handa JT
J Pathol; 2013 Apr; 229(5):729-42. PubMed ID: 23097248
[TBL] [Abstract][Full Text] [Related]
10. New therapeutic targets in atrophic age-related macular degeneration.
Petrukhin K
Expert Opin Ther Targets; 2007 May; 11(5):625-39. PubMed ID: 17465722
[TBL] [Abstract][Full Text] [Related]
11. Cuticular drusen: stars in the sky.
Boon CJ; van de Ven JP; Hoyng CB; den Hollander AI; Klevering BJ
Prog Retin Eye Res; 2013 Nov; 37():90-113. PubMed ID: 24028794
[TBL] [Abstract][Full Text] [Related]
12. Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis).
Umeda S; Suzuki MT; Okamoto H; Ono F; Mizota A; Terao K; Yoshikawa Y; Tanaka Y; Iwata T
FASEB J; 2005 Oct; 19(12):1683-5. PubMed ID: 16099945
[TBL] [Abstract][Full Text] [Related]
13. Drusen maculopathy: a risk factor for visual deterioration.
Algvere PV; Kvanta A; Seregard S
Acta Ophthalmol; 2016 Aug; 94(5):427-33. PubMed ID: 27009526
[TBL] [Abstract][Full Text] [Related]
14. Hyperhomocysteinemia and Age-related Macular Degeneration: Role of Inflammatory Mediators and Pyroptosis; A Proposal.
Singh M; Tyagi SC
Med Hypotheses; 2017 Aug; 105():17-21. PubMed ID: 28735646
[TBL] [Abstract][Full Text] [Related]
15. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited.
Anderson DH; Radeke MJ; Gallo NB; Chapin EA; Johnson PT; Curletti CR; Hancox LS; Hu J; Ebright JN; Malek G; Hauser MA; Rickman CB; Bok D; Hageman GS; Johnson LV
Prog Retin Eye Res; 2010 Mar; 29(2):95-112. PubMed ID: 19961953
[TBL] [Abstract][Full Text] [Related]
16. Drusen Volume and Retinal Pigment Epithelium Abnormal Thinning Volume Predict 2-Year Progression of Age-Related Macular Degeneration.
Folgar FA; Yuan EL; Sevilla MB; Chiu SJ; Farsiu S; Chew EY; Toth CA;
Ophthalmology; 2016 Jan; 123(1):39-50.e1. PubMed ID: 26578448
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress in dry age-related macular degeneration and exfoliation syndrome.
Chiras D; Kitsos G; Petersen MB; Skalidakis I; Kroupis C
Crit Rev Clin Lab Sci; 2015 Feb; 52(1):12-27. PubMed ID: 25319011
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenesis of dry age-related macular degeneration: updates].
Zhang GM; Chen Y
Zhonghua Yan Ke Za Zhi; 2014 Jun; 50(6):464-70. PubMed ID: 25241979
[TBL] [Abstract][Full Text] [Related]
19. C-Reactive Protein As a Mediator of Complement Activation and Inflammatory Signaling in Age-Related Macular Degeneration.
Chirco KR; Potempa LA
Front Immunol; 2018; 9():539. PubMed ID: 29599782
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on reticular pseudodrusen in age-related macular degeneration.
Sivaprasad S; Bird A; Nitiahpapand R; Nicholson L; Hykin P; Chatziralli I;
Surv Ophthalmol; 2016; 61(5):521-37. PubMed ID: 26994868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
